Randomized trial investigating the safety and efficacy of influenza vaccination in patients with antineutrophil cytoplasmic antibody‐associated vasculitis

Publisher： John Wiley & Sons Inc

E-ISSN： 1440-1797|20|5|343-351

ISSN： 1320-5358

Source： NEPHROLOGY, Vol.20, Iss.5, 2015-05, pp. : 343-351

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Influenza vaccination and anti‐neutrophil cytoplasmic antibody‐associated vasculitis

By  

NEPHROLOGY, Vol. 20, Iss. 7, 2015-07 ,pp. : 511-512

John Wiley & Sons Inc

Access to resources Recommend Favorite

Response to Wiwanitkit et al. comment on the report: ‘A randomised trial investigating the safety and efficacy of influenza vaccination in patients with ANCA‐associated vasculitis’

By  

NEPHROLOGY, Vol. 20, Iss. 8, 2015-08 ,pp. : 584-584

John Wiley & Sons Inc

Access to resources Recommend Favorite

Incidence of Malignancies in Patients With Antineutrophil Cytoplasmic Antibody–Associated Vasculitis Diagnosed Between 1991 and 2013

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 67, Iss. 12, 2015-12 ,pp. : 3270-3278

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical Outcome and Prognosis of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis in Japan

By  

Nephron Clin Pract, Vol. 115, Iss. 1, 2010-02 ,pp. : c21-c27

Karger

Access to resources Recommend Favorite

Rituximab for the Treatment of Relapses in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 66, Iss. 11, 2014-11 ,pp. : 3151-3159

John Wiley & Sons Inc

Access to resources Recommend Favorite